avVaa World Health Care Products Inc
OTC:AVVH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
avVaa World Health Care Products Inc
OTC:AVVH
|
CA |
|
M
|
Mori-Gumi Co Ltd
TSE:1853
|
JP |
Income Statement
Earnings Waterfall
avVaa World Health Care Products Inc
Income Statement
avVaa World Health Care Products Inc
| May-2005 | Aug-2005 | Nov-2005 | Feb-2006 | May-2006 | Aug-2006 | Nov-2006 | Feb-2007 | May-2007 | Aug-2007 | Nov-2007 | Feb-2008 | May-2008 | Aug-2008 | Nov-2008 | Feb-2009 | May-2009 | Aug-2009 | Nov-2009 | Feb-2010 | May-2010 | Aug-2010 | Aug-2011 | Nov-2011 | Feb-2012 | Aug-2012 | Nov-2012 | Feb-2013 | May-2013 | Aug-2013 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
+300%
|
0
+25%
|
0
N/A
|
0
-60%
|
0
-50%
|
0
+400%
|
0
+20%
|
0
+67%
|
0
-20%
|
0
-63%
|
0
-67%
|
0
+523%
|
0
-20%
|
0
N/A
|
0
N/A
|
0
-96%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+83%
|
0
-18%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+26%
|
0
-57%
|
0
+9%
|
0
+454%
|
0
+29%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
+100%
|
0
+50%
|
0
N/A
|
(0)
N/A
|
(0)
-50%
|
(0)
-33%
|
(0)
-50%
|
(0)
-483%
|
(0)
N/A
|
(0)
N/A
|
(0)
+6%
|
0
N/A
|
0
-9%
|
0
N/A
|
0
N/A
|
0
-100%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+30%
|
0
+15%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+21%
|
0
-60%
|
0
+10%
|
0
+476%
|
0
+30%
|
|
| Operating Income | |||||||||||||||||||||||||||||||
| Operating Expenses |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Selling, General & Administrative |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(3)
N/A
|
(3)
+1%
|
(3)
-1%
|
(3)
-4%
|
(3)
+2%
|
(3)
-19%
|
(3)
-10%
|
(3)
+2%
|
(3)
+7%
|
(2)
+24%
|
(2)
+24%
|
(1)
+21%
|
(1)
+24%
|
(1)
+28%
|
(1)
+27%
|
(1)
+7%
|
(1)
-20%
|
(1)
+18%
|
(1)
-15%
|
(1)
-12%
|
(1)
+14%
|
(1)
-13%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-254%
|
(0)
-159%
|
(0)
N/A
|
0
N/A
|
0
-2%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
2
|
2
|
4
|
(8)
|
4
|
(1)
|
(8)
|
7
|
(6)
|
2
|
2
|
(16)
|
0
|
(7)
|
(3)
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(10)
|
(10)
|
(9)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(3)
N/A
|
(3)
-8%
|
(4)
-9%
|
(4)
-16%
|
(4)
+5%
|
(1)
+70%
|
(2)
-37%
|
(1)
+10%
|
(4)
-200%
|
(20)
-358%
|
(8)
+62%
|
(12)
-60%
|
(14)
-9%
|
7
N/A
|
(7)
N/A
|
2
N/A
|
1
-53%
|
(17)
N/A
|
(0)
+97%
|
(8)
-1 598%
|
3
N/A
|
17
+531%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-254%
|
(0)
-159%
|
(0)
N/A
|
0
N/A
|
0
-2%
|
|
| Net Income | |||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(1)
|
(2)
|
(1)
|
(4)
|
(20)
|
(8)
|
(12)
|
(14)
|
7
|
(7)
|
2
|
1
|
(17)
|
(0)
|
(8)
|
3
|
17
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Net Income (Common) |
(3)
N/A
|
(3)
-8%
|
(4)
-9%
|
(4)
-16%
|
(4)
+5%
|
(1)
+70%
|
(2)
-37%
|
(1)
+10%
|
(4)
-200%
|
(20)
-358%
|
(8)
+62%
|
(12)
-60%
|
(14)
-9%
|
7
N/A
|
(7)
N/A
|
2
N/A
|
1
-58%
|
(17)
N/A
|
(1)
+97%
|
(8)
-1 307%
|
3
N/A
|
17
+531%
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-254%
|
(0)
-159%
|
(0)
N/A
|
0
N/A
|
0
-2%
|
|
| EPS (Diluted) |
-11.66
N/A
|
-9.41
+19%
|
-10.22
-9%
|
-9.93
+3%
|
-9.61
+3%
|
-1.95
+80%
|
-2.21
-13%
|
-1.06
+52%
|
-3.27
-208%
|
-3.22
+2%
|
-1.07
+67%
|
-1.65
-54%
|
-1.88
-14%
|
0
N/A
|
-0.25
N/A
|
0
N/A
|
0
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
0
N/A
|
0.01
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|